We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

2 hedge funds and large institutions have $3.44M invested in Albany Molecular Research Inc in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 133 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 136 → 2 (-134)

99% less capital invested

Capital invested by funds: $677M → $3.44M (-$674M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 133

Holders
2
Holders Change
-134
Holders Change %
-98.53%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
133
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$871K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$80M
2
ACM
American Capital Management
New York
-$55.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$52M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$33.9M
5
Citigroup
Citigroup
New York
-$30.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
76
Prudential Financial
New Jersey
– -$820K -37,770 Closed
Bank of America
77
Bank of America
North Carolina
– -$808K -37,238 Closed
PPA
78
Parametric Portfolio Associates
Washington
– -$792K -36,483 Closed
CI
79
Cowen Inc
New York
– -$760K -35,000 Closed
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
– -$748K -34,476 Closed
SO
81
STRS Ohio
Ohio
– -$722K -33,300 Closed
Canada Life
82
Canada Life
Manitoba, Canada
– -$673K -31,036 Closed
New York State Common Retirement Fund
83
New York State Common Retirement Fund
New York
– -$564K -26,000 Closed
TSS
84
Two Sigma Securities
New York
– -$544K -25,071 Closed
LBC
85
Lawrence B. Cohen
– -$540K -24,875 Closed
GCP
86
GSA Capital Partners
United Kingdom
– -$535K -24,670 Closed
ProShare Advisors
87
ProShare Advisors
Maryland
– -$535K -24,659 Closed
Comerica Bank
88
Comerica Bank
Texas
– -$521K -24,023 Closed
New York State Teachers Retirement System (NYSTRS)
89
New York State Teachers Retirement System (NYSTRS)
New York
– -$482K -22,193 Closed
Skandinaviska Enskilda Banken (SEB)
90
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$467K -21,500 Closed
State of Tennessee, Department of Treasury
91
State of Tennessee, Department of Treasury
Tennessee
– -$457K -21,078 Closed
Manulife (Manufacturers Life Insurance)
92
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$443K -20,412 Closed
JG
93
Jefferies Group
New York
– -$414K -19,065 Closed
AIG
94
American International Group
New York
– -$411K -18,950 Closed
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
– -$410K -18,917 Closed
Group One Trading
96
Group One Trading
Illinois
– -$395K -18,203 Closed
AG
97
Aperio Group
California
– -$381K -17,570 Closed
TPSF
98
Texas Permanent School Fund
Texas
– -$354K -16,299 Closed
AI
99
Atria Investments
North Carolina
– -$350K -16,137 Closed
ClearBridge Investments
100
ClearBridge Investments
New York
– -$332K -15,310 Closed
2 3
4
5 6

AMRI Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2017, worth a combined $3.44M — down 99% from $677M a quarter earlier.

Sellers outnumbered buyers: 133 funds closed out of AMRI and 0 opened new positions — a net loss of 133 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Ancora Advisors, adding an estimated $871K. The largest seller was BlackRock, exiting entirely with an estimated $80M sold.

  • 2 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2017, down from 136 in Q2 2017.
  • Funds reported $3.44M of Albany Molecular Research Inc stock for Q3 2017, down 99% quarter-over-quarter.
  • 0 funds opened new Albany Molecular Research Inc positions in Q3 2017 and 133 closed out, a net change of -133 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2017 was Ancora Advisors, an estimated $871K added.
  • The largest Albany Molecular Research Inc seller in Q3 2017 was BlackRock, an estimated $80M sold.

Based on aggregated 13F filings for Q3 2017.